Topic

Articles

The MIT Institute for Work and Employment Research’s Dr. Thomas Kochan offers three key insights on engaging with AI and other digital solutions as they continue to transform the working environment.

Shaping the Future of Work in An Ever-Accelerating AI World

Acute Care Pharmacy Resident, UNC Medical Center

Co-founder, President, and CEO of Sensal Health

Comprehensive dosage monitoring of topical treatments for mild to moderate psoriasis.

How Technology Can be Used to Improve Adherence

Dr. John Price is an executive physician with 25+ years deep experience working across regulatory affairs and pharmacovigilance worldwide. He has held senior roles at the UK MHRA, as well as Pfizer, J&J, Alexion Pharmaceuticals, and worked in academia. John is an advisor to 

, a provider of risk management and compliance services to the life sciences sector – including market consultancy, global regulatory affairs strategy and implementation, complete PV solutions, clinical drug safety, and quality and compliance auditing systems.

According to new research, quality has overtaken cost as a priority in plans for automating adverse event reporting. John Price reveals the drivers and barriers to change.

Quality More Important than Cost: Building the Business Case for PV Automation

Gareth Shaw is President, UK & Europe of Doceree, the first global network of physician-only platforms for programmatic messaging. Gareth has an extensive background in the sales categories across the digital media and advertising technology sectors. Throughout his career, Gareth has a history of building high-performance teams and implementing strategic plans to facilitate the growth of his organizations. 

Healthcare professionals (HCPs) shouldn’t miss out on critical information while their focus is on their patients, which is why messages on professional platforms are an essential resource to improve a patient’s health results, writes Gareth Shaw.

Using Identity Resolution Technology to Dispense Hyper-Relevant Information to HCPs

Brian Flatley is VP Consulting Services at 

How can pharma create solutions that are effective, can provide long-term value, and will actually be adopted by HCPs and patients?

Why Pharma Should Develop a Core Digital Offering

Industry leaders share perspectives on moving the life sciences industry forward.

Expert Roundup: How Technology is Shaping the Future of Life Sciences

's Online and European Editor. He can be reached at jupton@mjhlifesciences.com

Traditionally difficult in pharma, data science recruitment witnessed a sharp drop-off at the beginning of the pandemic, but interest has since bounced back to unexpected levels.

COVID and the Data Talent Turnabout

Chris Doerr, Senior Vice President, Global Generic Sourcing, AmerisourceBergen, talks about the importance of companies taking an honest view of their current-state capabilities when embarking on the digital transformation journey.





Avoiding the Shiny Penny Syndrome of Digital Transformation

Jim Williams is an associate director in Life Sciences at Guidehouse.

Jacob Graham is a partner in the Life Sciences practice at Guidehouse.

Creating a digital diagnostic that is supplemental and strategic to a company’s therapeutic asset requires due diligence to monetize the digital health innovation, or at least ensure optionality through the product development cycle.

Four Critical Considerations for Launching Digital Diagnostic Tools

Clay Hausmann is CMO and SVP, Strategic Alliances, Aktana.

Clay Hausmann describes how Almirall is weeding out uncertainty to sow the seeds of data-driven digital transformation.